Novartis Pharma is leading an initiative to promote the use of gene expression biomarkers in drug development. As part of this initiative, Novartis set the challenge for Integromics to develop a high- throughput workflow that addresses their large volume of data analysis needs, while still maintaining the security and statistical analysis requirements necessary for such kind of studies. The project was successfully completed and we are now pleased to invite you to see how the result of this work will break new frontiers in large qPCR projects.

During this webinar, you will learn:

• The results of Integromics and Novartis effort, our new qPCR high-throughput workflow of RealTime StatMiner® for Applied Biosystems technology
• How to use RealTime StatMiner® Quality Control steps for a successful analysis of qPCR data
• How RealTime StatMiner® eliminates the need to have several applications and interfaces to perform the data analysis
• How to reduce the completion time of qPCR Experimental Reports, including gene fold change and the clustering of samples

1. All existing RealTime StatMiner® users will receive this upgrade as part of the new release.


We look forward to your feedback.


Your Integromics Team